Three-year duration of benefit from abciximab in patients receiving stents for acute myocardial infarction in the randomized double-blind ADMIRAL study (Q36297058)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Three-year duration of benefit from abciximab in patients receiving stents for acute myocardial infarction in the randomized double-blind ADMIRAL study |
scientific article |
Statements
1 reference
Three-year duration of benefit from abciximab in patients receiving stents for acute myocardial infarction in the randomized double-blind ADMIRAL study (English)
1 reference
Admiral Investigators
1 reference
25 October 2005
1 reference
1 reference
26
1 reference
23
1 reference
2520-2523
1 reference
Identifiers
1 reference
1 reference